FDA goes beyond the label to educate doctors—and enlighten others—about new cancer drugs bbulik Tue, 12/01/2020 – 09:28
Month: December 2020
Halozyme scores $190M Horizon deal to develop subQ Tepezza formula fkansteiner Tue, 12/01/2020 – 09:24
Why isn’t Pfizer’s COVID vaccine OK’d yet? White House calls in FDA chief Hahn to explain: Axios esagonowsky […]
Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests […]
A machine learning model can help us treat cancer more effectively.
An inexpensive, FDA-approved drug — cholestyramine — taken in conjunction with an antibiotic prevents the antibiotic from driving […]
Researchers from Bochum, Göttingen, Duisburg and Cologne have developed a new method for detecting bacteria and infections. They […]
Bacterial infections have become one of the biggest health problems worldwide, and a recent study shows that COVID-19 […]
A mass screening programme of more than 10 million residents of Wuhan, China, performed after SARS-CoV-2 was brought […]
Exact details of the £542.9m (€605.8m; $725m) that drug companies spent on healthcare organisations and healthcare professionals in […]